Luteolin-Loaded Spion as a Drug Carrier for Cancer Cell In Vitro

被引:7
作者
Alpsoy, L. [1 ]
Baykal, A. [2 ]
Akal, Z. U. [1 ]
机构
[1] Gama Mechatron Co, TR-16159 Nilufer Bursa, Turkey
[2] Univ Dammam, IRMC, Dept Nanomed Res, POB 1982, Dammam 31441, Saudi Arabia
关键词
SPION; Luteolin; Cancer treatment; Nanodrug; Drug delivery; OXIDE NANOPARTICLES SPIONS; GLIOBLASTOMA CELLS; PROSTATE-CANCER; CYCLE ARREST; APOPTOSIS; VIVO; NANOTECHNOLOGY; PREVENTION; DELIVERY; PROLIFERATION;
D O I
10.1007/s10948-017-4199-x
中图分类号
O59 [应用物理学];
学科分类号
摘要
The aim of this study is to determine the cytotoxic and apoptotic effects of newly synthesized folic acid (FA) and luteolin (carboxylated luteolin (CL)) conjugated superparamagnetic nanoparticle (SPION@FA-PEG@CL) on folate receptor positive (FAR (+)) and negative (FAR (-)) cell lines in vitro. Cytotoxicity analysis by real-time cell analyzer system (RTCA) and apoptosis by TUNEL and Annexin assay, Caspase 3/7 activities, and Caspase 3/7 expression level were determined. According to RTCA results, SPION@FA-PEG@CL nanodrug showed higher cytotoxicity against U87, MCF-7, HeLa cell lines in comparison with L929 and A549 cell lines. TUNEL and Annexin assays indicated that SPION@FA-PEG@CL increased the apoptotic and necrotic cell ratio in FAR (+) cell. In L929 and A549 cells, are FAR (-) cell lines apoptotic and necrotic cell ratio was lower than FAR (+) cell lines (U87, MCF-7 and HeLa). Caspase 3 and 7 analyses also showed that SPION@FA-PEG@CL nanodrug have apoptotic and necrotic impact on cell lines, they were higher in FAR (+) cells than FAR (-) cells. According to results, synthesized SPION@FA-PEG@CL can be a novel nanodrug delivery system for in cancer chemotherapy.
引用
收藏
页码:467 / 474
页数:8
相关论文
共 35 条
[1]   Superparamagnetic iron oxide conjugated with folic acid and carboxylated quercetin for chemotherapy applications [J].
Akal, Z. U. ;
Alpsoy, L. ;
Baykal, A. .
CERAMICS INTERNATIONAL, 2016, 42 (07) :9065-9072
[2]  
Alpsoy L., J SUPERCOND NOV MAGN, DOI [10.1007/s10948-017-4056, DOI 10.1007/S10948-017-4056]
[3]   Perspectives for Cancer Prevention With Natural Compounds [J].
Amin, A. R. M. Ruhul ;
Kucuk, Omer ;
Khuri, Fadlo R. ;
Shin, Dong M. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (16) :2712-2725
[4]   Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo [J].
Chakrabarti, Mrinmay ;
Ray, Swapan K. .
APOPTOSIS, 2016, 21 (03) :312-328
[5]  
Chen Q, 2012, NAT PROD COMMUN, V7, P29
[6]   Luteolin inhibits migration of human glioblastoma U-87 MG and T98G cells through downregulation of Cdc42 expression and PI3K/AKT activity [J].
Cheng, Wen-Yu ;
Chiao, Ming-Tsang ;
Liang, Yea-Jiuen ;
Yang, Yi-Chin ;
Shen, Chiung-Chyi ;
Yang, Chiou-Ying .
MOLECULAR BIOLOGY REPORTS, 2013, 40 (09) :5315-5326
[7]   Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration [J].
Chertok, Beata ;
David, Allan E. ;
Yang, Victor C. .
BIOMATERIALS, 2010, 31 (24) :6317-6324
[8]   Role of chemopreventive agents in cancer therapy [J].
Dorai, T ;
Aggarwal, BB .
CANCER LETTERS, 2004, 215 (02) :129-140
[9]  
Elkhodiry M. A., 2016, ANTICANCER AGENTS ME
[10]   Cancer nanotechnology: Opportunities and challenges [J].
Ferrari, M .
NATURE REVIEWS CANCER, 2005, 5 (03) :161-171